SARS-CoV-2 BA.2.75 spike glycoprotein (closed state 1)
Resolution: 2.86 Å
EM Method: Single-particle
Fitted PDBs: 8gs6
Q-score: 0.531
Saito A, Tamura T, Zahradnik J, Deguchi S, Tabata K, Anraku Y, Kimura I, Ito J, Yamasoba D, Nasser H, Toyoda M, Nagata K, Uriu K, Kosugi Y, Fujita S, Shofa M, Monira Begum M, Shimizu R, Oda Y, Suzuki R, Ito H, Nao N, Wang L, Tsuda M, Yoshimatsu K, Kuramochi J, Kita S, Sasaki-Tabata K, Fukuhara H, Maenaka K, Yamamoto Y, Nagamoto T, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Ueno T, Schreiber G, Takaori-Kondo A, Shirakawa K, Sawa H, Irie T, Hashiguchi T, Takayama K, Matsuno K, Tanaka S, Ikeda T, Fukuhara T, Sato K
Cell Host Microbe (2022) 30 pp. 1540-1555.e15 [ DOI: doi:10.1016/j.chom.2022.10.003 Pubmed: 36272413 ]
SARS-CoV-2 BA.2.75 spike glycoprotein (closed state 2)
Saito A, Tamura T, Zahradnik J, Deguchi S, Tabata K, Anraku Y, Kimura I, Ito J, Yamasoba D, Nasser H, Toyoda M, Nagata K, Uriu K, Kosugi Y, Fujita S, Shofa M, Monira Begum M, Shimizu R, Oda Y, Suzuki R, Ito H, Nao N, Wang L, Tsuda M, Yoshimatsu K, Kuramochi J, Kita S, Sasaki-Tabata K, Fukuhara H, Maenaka K, Yamamoto Y, Nagamoto T, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Ueno T, Schreiber G, Takaori-Kondo A, Shirakawa K, Sawa H, Irie T, Hashiguchi T, Takayama K, Matsuno K, Tanaka S, Ikeda T, Fukuhara T, Sato K
Cell Host Microbe (2022) 30 pp. 1540-1555.e15 [ DOI: doi:10.1016/j.chom.2022.10.003 Pubmed: 36272413 ]
SARS-CoV-2 BA.2.75 spike glycoprotein (1-up state)
Saito A, Tamura T, Zahradnik J, Deguchi S, Tabata K, Anraku Y, Kimura I, Ito J, Yamasoba D, Nasser H, Toyoda M, Nagata K, Uriu K, Kosugi Y, Fujita S, Shofa M, Monira Begum M, Shimizu R, Oda Y, Suzuki R, Ito H, Nao N, Wang L, Tsuda M, Yoshimatsu K, Kuramochi J, Kita S, Sasaki-Tabata K, Fukuhara H, Maenaka K, Yamamoto Y, Nagamoto T, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Ueno T, Schreiber G, Takaori-Kondo A, Shirakawa K, Sawa H, Irie T, Hashiguchi T, Takayama K, Matsuno K, Tanaka S, Ikeda T, Fukuhara T, Sato K
Cell Host Microbe (2022) 30 pp. 1540-1555.e15 [ DOI: doi:10.1016/j.chom.2022.10.003 Pubmed: 36272413 ]
SARS-CoV-2 BA.2.75 spike glycoprotein in complex with ACE2
Saito A, Tamura T, Zahradnik J, Deguchi S, Tabata K, Anraku Y, Kimura I, Ito J, Yamasoba D, Nasser H, Toyoda M, Nagata K, Uriu K, Kosugi Y, Fujita S, Shofa M, Monira Begum M, Shimizu R, Oda Y, Suzuki R, Ito H, Nao N, Wang L, Tsuda M, Yoshimatsu K, Kuramochi J, Kita S, Sasaki-Tabata K, Fukuhara H, Maenaka K, Yamamoto Y, Nagamoto T, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Ueno T, Schreiber G, Takaori-Kondo A, Shirakawa K, Sawa H, Irie T, Hashiguchi T, Takayama K, Matsuno K, Tanaka S, Ikeda T, Fukuhara T, Sato K
Cell Host Microbe (2022) 30 pp. 1540-1555.e15 [ DOI: doi:10.1016/j.chom.2022.10.003 Pubmed: 36272413 ]
- Sars-cov-2 ba.2.75 spike glycoprotein (Protein from Severe acute respiratory syndrome coronavirus 2)
- Sars-cov-2 ba.2.75 spike glycoprotein (420 kDa, Complex from Severe acute respiratory syndrome coronavirus 2)
- Human angiotensin-converting enzyme 2 (80 kDa, Complex from Homo sapiens)
- Human angiotensin-converting enzyme 2 (Protein from Homo sapiens)
- Sars-cov-2 ba.2.75 spike glycoprotein in complex with ace2 (500 kDa, Complex)